•
VR
VRCA
Verrica Pharmaceuticals Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
124.08M
Volume
104.80K
52W High
$9.82
52W Low
$3.28
Open
$0.00
Prev Close
$7.94
Day Range
0.00 - 0.00
About Verrica Pharmaceuticals Inc. Common Stock
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Latest News
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
GlobeNewswire Inc.•Jan 7
Verrica Posts Profit in Fiscal Q2
The Motley Fool•Aug 13
Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference
GlobeNewswire Inc.•Oct 24
Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
GlobeNewswire Inc.•Aug 14
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
GlobeNewswire Inc.•Jul 1
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
GlobeNewswire Inc.•May 15
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga•May 14
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 13